©The Author(s) 2023.
World J Clin Cases. Jan 6, 2023; 11(1): 104-115
Published online Jan 6, 2023. doi: 10.12998/wjcc.v11.i1.104
Published online Jan 6, 2023. doi: 10.12998/wjcc.v11.i1.104
Table 3 Determinant of treatment outcome, n (%)
| Treatment Outcome | |||||||
| Completed | Loss to follow up | Total | χ2 | DF | P value | ||
| Gender | Male | 88 (33.6) | 53 (20.2) | 141 (53.8) | 1.336 | 1 | 0.248 |
| Female | 67 (25.6) | 54 (20.6) | 121 (46.2) | ||||
| Total | 155 (59.2) | 107 (40.8) | 262 (100.0) | ||||
| Age | 0-24 | 57 (55.3) | 46 (44.7) | 103 (40.2) | 4.114 | 2 | 0.128 |
| 25-48 | 62 (68.1) | 29 (31.9) | 91 (35.5) | ||||
| 49 and above | 34 (54.8) | 28 (45.2) | 62 (24.2) | ||||
| Total | 153 (59.8) | 103 (40.2) | 256 (100.0) | ||||
| Type of facility | PFP | 103 (39.3) | 70 (26.7) | 173 (66.0) | 0.030 | 1 | 0.862 |
| PNFP | 52 (19.8) | 37 (14.1) | 89 (34.0) | ||||
| Total | 155 (59.2) | 107 (40.8) | 262 (100.0) | ||||
- Citation: Adepoju VA, Adelekan A, Agbaje A, Quaitey F, Ademola-Kay T, Udoekpo AU, Sokoya OD. Completion of 6-mo isoniazid preventive treatment among eligible under six children: A cross-sectional study, Lagos, Nigeria. World J Clin Cases 2023; 11(1): 104-115
- URL: https://www.wjgnet.com/2307-8960/full/v11/i1/104.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i1.104